{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:03:09Z","timestamp":1787688189835,"version":"build-2784847793"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>U.S. policy intervention to increase methadone treatment accommodations during COVID did not result in national adoption of the new patient-centered treatment practices. Staff-level interventions may facilitate adoption of these treatment practices, but this will depend upon knowledge about staff level characteristics and beliefs. Currently, the role of clinic staff characteristics, beliefs about patient-centeredness, and perceptions about the need for treatment practice change is unknown. This study explored the relationship between opioid treatment program staff characteristics, work roles and staff beliefs to identify opportunities for future staff-level treatment practice change interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Staff of three Arizona opioid treatment programs were surveyed (n\u2009=\u200940) from April 11\u201322, 2023 using a hybrid online survey method. The 161 survey items required less than 30\u00a0min to complete. Pearson point biserial correlation coefficients assessed the covariation between staff beliefs, staff characteristics and staff work roles. Perception of the clinic as person-centered was a potential proxy indicator for staff awareness of discontinuity between the clinic\u2019s person-centeredness and person-centered approaches to methadone treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among staff, 47.5% reported lived substance use disorder experience and 27.5% reported lived opioid use disorder experience. Most staff (70%) held at least 1 prior clinic role at the current clinic and 5% had had more than 4 prior roles. Rotation was observed with roles that did not require licensure or degrees. Staff with lived experience with substance use disorder or opioid use disorder treatment reported having more prior roles at the clinic than those without such experience. Abstinence-oriented views were significantly associated with reporting vicarious (work related) trauma symptoms. Those who rated the clinic as significantly more person-centered were staff with lived substance use disorder experience who also held abstinence-oriented views, staff with trauma exposure, and staff with lived opioid use disorder treatment experience who held harm reduction beliefs. In contrast, staff without substance use disorder experience who held harm reduction beliefs perceived the clinic as less person-centered.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Staff beliefs, personal and work characteristics are likely factors in the recognition of need for clinic practice change. How these characteristics function in a clinic culture may also be influenced by clinic staffing patterns. A patient-to-provider pipeline with role cycling was observed and this staffing pattern may also influence shared beliefs of trauma-informed care or clinic person-centeredness. Vicarious trauma may also be an important factor. Larger studies should examine these relationships further to understand mechanisms associated with recognition of need for clinic practice change in order to inform staff-level interventions to increase opioid treatment program patient-centeredness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-024-00501-6","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:01:22Z","timestamp":1733011282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-7179","authenticated-orcid":false,"given":"Beth E.","family":"Meyerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea B.","family":"Linde-Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"De La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allie","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,1]]},"reference":[{"issue":"2","key":"501_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson C, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2): e1920622.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"501_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","volume":"28","author":"L Amato","year":"2005","unstructured":"Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28(4):321\u20139.","journal-title":"J Subst Abuse Treat"},{"key":"501_CR3","unstructured":"Institute of Medicine Committee on Federal Regulation of Methadone Treatment. Federal Regulation of Methadone Treatment. In: Rettig RA, Yarmolinsky A, Eds. Federal Regulation of Methadone Treatment. National Academies Press; 1995:120\u2013150."},{"issue":"6","key":"501_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1049732311432718","volume":"22","author":"J Harris","year":"2012","unstructured":"Harris J, McElrath K. Methadone as social control: institutionalized stigma and the prospect of recovery. Qual Health Res. 2012;22(6):810\u201324. https:\/\/doi.org\/10.1177\/1049732311432718.","journal-title":"Qual Health Res"},{"key":"501_CR5","unstructured":"Drug Addiction Treatment Act, 1101, \u00a73501. 2000. https:\/\/www.govinfo.gov\/content\/pkg\/PLAW-106publ310\/pdf\/PLAW-106publ310.pdf. Accessed 24 Mar 2020."},{"key":"501_CR6","unstructured":"Pew Charitable Trusts. Overview of opioid treatment program regulations by state: restrictive rules put evidence-based medication treatment out of reach for many. September 2022. See https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/data-visualizations\/2022\/state-opioid-treatment-program-regulations-put-evidence-based-care-out-of-reach-for-many and https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/issue-briefs\/2022\/09\/overview-of-opioid-treatment-program-regulations-by-state"},{"key":"501_CR7","unstructured":"U.S. Substance abuse and mental health services administration. Federal guidelines for opioid treatment programs. Substance Abuse and Mental Health Services Administration; 2015."},{"key":"501_CR8","doi-asserted-by":"crossref","unstructured":"Henry-Edwards S, Gowing L, White J, Ali R, Bell J, Brough R, Lintzeris N, Ritter A, Quigley A. Clinical guidelines and procedures for the use of methadone in the maintenance and treatment of opioid dependence. Publications Production Unit, Australian Government Department of Health and Ageing, 2003; Publication approval number: 3263 (JN 7616).","DOI":"10.1037\/e677012010-001"},{"issue":"6","key":"501_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","volume":"34","author":"SL Calcaterra","year":"2019","unstructured":"Calcaterra SL, Chadi BPA, et al. Methadone matters: What the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 2019;34(6):1039\u201342.","journal-title":"J Gen Intern Med"},{"key":"501_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13643-021-01764-9","volume":"10","author":"J Klimas","year":"2021","unstructured":"Klimas J, Hamilton M-A, Gorfinkel L, Adam A, Cullen W, Wood E. Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials. Syst Rev. 2021;10:216. https:\/\/doi.org\/10.1186\/s13643-021-01764-9.","journal-title":"Syst Rev"},{"issue":"1","key":"501_CR11","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2020.07","volume":"35","author":"M Moradinazar","year":"2020","unstructured":"Moradinazar M, Farnia V, Alikhani M, Karyani AK, Rezaei S, Rezaeian S, Matin BK, Najafi F. Factors related to relapse in patients with substance-related disorders under methadone maintenance therapy: decision tree analysis. Oman Med J. 2020;35(1): e89. https:\/\/doi.org\/10.5001\/omj.2020.07.","journal-title":"Oman Med J"},{"key":"501_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108197","volume":"121","author":"KE Dunn","year":"2021","unstructured":"Dunn KE, Brooner RK, Stoller KB. Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the COVID-19 pandemic. J Sub Abuse Treat. 2021;121: 108197. https:\/\/doi.org\/10.1016\/j.jsat.2020.108197.","journal-title":"J Sub Abuse Treat"},{"key":"501_CR13","unstructured":"U.S. Substance Abuse and Mental Health Services Administration (SAMHSA). Opioid Treatment Program Directory. https:\/\/dpt2.samhsa.gov\/treatment\/directory.aspx Accessed 23 April 2024."},{"key":"501_CR14","unstructured":"U.S. Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2021"},{"key":"501_CR15","first-page":"1","volume":"123","author":"MC Figgatt","year":"2021","unstructured":"Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. J Subst Abust Treat. 2021;123:1\u20134.","journal-title":"J Subst Abust Treat"},{"issue":"3","key":"501_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/ADM.0b013e3182584772","volume":"6","author":"AY Walley","year":"2012","unstructured":"Walley AY, Cheng DM, Pierce CE, Chen C, Filippell T, Samet JH, Alford DP. methadone dose, take home status, and hospital admission among methadone maintenance patients. J Addict Med. 2012;6(3):186\u201390.","journal-title":"J Addict Med"},{"key":"501_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"D Frank","year":"2021","unstructured":"Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Honoria G. \u201cIt\u2019s like \u2018liquid handcuffs\u201d: the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients\u2019 lives. Harm Reduct J. 2021;18:88.","journal-title":"Harm Reduct J"},{"key":"501_CR18","unstructured":"Russell DM. To a US methadone recipient, visiting Australia was shocking. Filter 2022; December 20. [online]: https:\/\/filtermag.org\/methadone-clinic-australia-pharmacy\/ Accessed 12 Feb 2023."},{"key":"501_CR19","unstructured":"Russell DM. Naturally Non-compliant: mandatory counseling in methadone clinics. (Unpublished doctoral dissertation). Arizona State University. Tempe, Arizona. 2023."},{"key":"501_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13722-021-00251-9","volume":"16","author":"K Marshall","year":"2021","unstructured":"Marshall K, Maina G, Sherstobitoff J. Plausibility of patient-centered care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract. 2021;16:42.","journal-title":"Addict Sci Clin Pract"},{"key":"501_CR21","doi-asserted-by":"publisher","DOI":"10.1377\/forefront.20230531.974690","author":"D Bowser","year":"2023","unstructured":"Bowser D, Bohler R, Davis MT, Hodgkin D, Frank RG, Horgan CM. New methadone treatment regulations should be complemented by payment and financing reform. Health Affairs Forefront. 2023. https:\/\/doi.org\/10.1377\/forefront.20230531.974690.","journal-title":"Health Affairs Forefront"},{"key":"501_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"501_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0740-5472(95)00025-Z","volume":"12","author":"RE Villag\u00f3mez","year":"1995","unstructured":"Villag\u00f3mez RE, Meyer TJ, Lin MM, Brown LS. Post-traumatic stress disorder among inner city methadone maintenance patients. J Subst Abuse Treat. 1995;12(4):253\u20137.","journal-title":"J Subst Abuse Treat"},{"key":"501_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","volume":"232","author":"EF Madden","year":"2019","unstructured":"Madden EF. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med. 2019;232:324\u201331. https:\/\/doi.org\/10.1016\/j.socscimed.2019.05.027.","journal-title":"Soc Sci Med"},{"key":"501_CR25","unstructured":"National Institutes of Health. 1997. The NIH Consensus Development Program: Effective Medical Treatment of Opiate Addiction [Consensus Development Conference Statement]. https:\/\/consensus.nih.gov\/1997\/1998treatopiateaddiction108html.htm"},{"key":"501_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968","volume":"211","author":"PJ Joudrey","year":"2020","unstructured":"Joudrey PJ, Chadi N, Roy P, Morford K, Bach P, Kimmel S, Wang EA, Calcaterra SL. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study. Drug Alco Depend. 2020;211: 107968.","journal-title":"Drug Alco Depend"},{"issue":"7","key":"501_CR27","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/jama.288.7.850","volume":"88","author":"T D\u2019Aunno","year":"2002","unstructured":"D\u2019Aunno T, Pollack H. Changes in methadone treatment practices: results from a national panel study, 1988\u20132000. JAMA. 2002;88(7):850\u20136.","journal-title":"JAMA"},{"key":"501_CR28","unstructured":"United States Substance Abuse and Mental Health Services Administration (SAMHSA). FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency, April 21, 2020. https:\/\/tinyurl.com\/sxbcnh3"},{"key":"501_CR29","unstructured":"Health and Human Services, Substance Abuse and Mental Health Services Administration. Code of Federal Regulations 42 Part 8: Medications for the Treatment of Opioid Use Disorder. [https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024-01693\/medications-for-the-treatment-of-opioid-use-disorder} Accessed 23 April 2024."},{"key":"501_CR30","doi-asserted-by":"publisher","first-page":"108514","DOI":"10.1016\/j.jsat.2021.108514","volume":"132","author":"PC Treitler","year":"2022","unstructured":"Treitler PC, Bowdewn CF, Lloyd J, Enich M, Nyaku AN, Crystal S. Perspectives of opioid use disorder treatment providers during COVID-19: adapting to flexibilities and sustaining reforms. J Sub Ab Treat. 2022;132:108514.","journal-title":"J Sub Ab Treat"},{"key":"501_CR31","unstructured":"Krawczyk N. Lessons learned from COVID-19 and regulatory change in the wake of necessity. Report to the National Academies of Science, 2022. https:\/\/www.nationalacademies.org\/documents\/embed\/link\/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B\/file\/D3E063A30D9D988E5EB95D66B10AABA47900519FC319"},{"key":"501_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100177","author":"BE Meyerson","year":"2023","unstructured":"Meyerson BE, Bentele KG, Brady BR, Stavros N, Russell DM, Mahoney A, Garnett I, Jackson S, Garcia RC, Coles H, Granillo B, Carter GA. Insufficient impact: Limited implementation of federal regulatory changes to methadone and buprenorphine access in Arizona during COVID. Am J Prev Med Focus. 2023. https:\/\/doi.org\/10.1016\/j.focus.2023.100177.","journal-title":"Am J Prev Med Focus"},{"key":"501_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108449","volume":"131","author":"S Brothers","year":"2021","unstructured":"Brothers S, Viera A, Heimer R. Changes in methadone program practices and fatal methadone overdose rates in connecticut during COVID-19. J Sub Abuse Treat. 2021;131: 108449.","journal-title":"J Sub Abuse Treat"},{"issue":"10","key":"501_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274094","volume":"17","author":"BE Meyerson","year":"2022","unstructured":"Meyerson BE, Bentele KG, Russell DM, Brady BR, Downer M, Garcia RC, Garnett I, Lutz R, Mahoney A, Samorano S, Arredondo C, Andres HJ, Coles H, Granillo B. Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID. PLoS ONE. 2022;17(10): e0274094.","journal-title":"PLoS ONE"},{"issue":"10","key":"501_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamapsychiatry.2022.2284","volume":"79","author":"CM Jones","year":"2022","unstructured":"Jones CM, Shoff C, Hodges K, et al. Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiat. 2022;79(10):981\u201392.","journal-title":"JAMA Psychiat"},{"key":"501_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11414-021-09784-y","volume":"49","author":"AD Mandavia","year":"2022","unstructured":"Mandavia AD, Campbell A, Henry BF, et al. Support for COVID-19-related substance use services policy changes: a New York state-wide survey. J Behav Health Serv Res. 2022;49:262\u201381. https:\/\/doi.org\/10.1007\/s11414-021-09784-y.","journal-title":"J Behav Health Serv Res"},{"key":"501_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jsat.2006.12.026","volume":"33","author":"BE Fuller","year":"2007","unstructured":"Fuller BE, Rieckmann T, Nunes EV, Miller M, Arfken C, Edmundson E, McCarty D. Organizational readiness for change and opinions toward treatment innovations. J Sub Abuse Treat. 2007;33:183\u201392. https:\/\/doi.org\/10.1016\/j.jsat.2006.12.026.","journal-title":"J Sub Abuse Treat"},{"key":"501_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2022.208947","volume":"145","author":"JA Frimpong","year":"2023","unstructured":"Frimpong JA, Guerrero EG, Kong Y, Khachikian T, Wang S, D\u2019Aunno T, Howard DL. Predicting and responding to change: perceived environmental uncertainty among substance use disorder treatment programs. J Sub Use Addic Treat. 2023;145: 208947. https:\/\/doi.org\/10.1016\/j.josat.2022.208947.","journal-title":"J Sub Use Addic Treat"},{"key":"501_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2022.211.5853","author":"E Pasman","year":"2022","unstructured":"Pasman E, Lee G, Kollin R, Rodriguez B, Agius E, Madden EF, Resko SM. Attitudes toward medication for opioid use disorder among substance use treatment providers. Subs Misuse. 2022. https:\/\/doi.org\/10.1080\/10826084.2022.211.5853.","journal-title":"Subs Misuse"},{"issue":"1","key":"501_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08897077.2015.1062457","volume":"37","author":"L Aletraris","year":"2016","unstructured":"Aletraris L, Edmond MB, Paino M, Fields D, Roman PM. Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Substance Abuse. 2016;37(1):47\u201353. https:\/\/doi.org\/10.1080\/08897077.2015.1062457.","journal-title":"Substance Abuse"},{"key":"501_CR41","doi-asserted-by":"publisher","DOI":"10.1080\/16066359.2022.2101640","author":"MJ Broman","year":"2022","unstructured":"Broman MJ, Pasman E, Brown S, Lister JJ, Agius E, Resko SM. Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment. Addict Res Theor. 2022. https:\/\/doi.org\/10.1080\/16066359.2022.2101640.","journal-title":"Addict Res Theor"},{"key":"501_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146","volume":"119","author":"K Cioe","year":"2020","unstructured":"Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder. J Sub Abuse Treat. 2020;119: 108146.","journal-title":"J Sub Abuse Treat"},{"key":"501_CR43","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1177\/0886260510383020","volume":"26","author":"SR Jenkins","year":"2010","unstructured":"Jenkins SR, Mitchell JL, Baird S, Whitfield SR, Meyer HL. The counselor\u2019s trauma as counseling motivation: vulnerability or stress inoculation. J Interpers Violence. 2010;26:2392\u2013412.","journal-title":"J Interpers Violence"},{"issue":"4","key":"501_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/08897077.2016.1181695","volume":"37","author":"M Cosden","year":"2016","unstructured":"Cosden M, Sanford A, Korch LM, Lepore CE. Vicarious trauma and vicarious posttraumatic growth among substance abuse treatment providers. Sub Abuse. 2016;37(4):619\u201324.","journal-title":"Sub Abuse"},{"issue":"2","key":"501_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/15548732.2015.1021987","volume":"9","author":"JS Middleton","year":"2015","unstructured":"Middleton JS, Potter CC. Relationship between vicarious traumatization and turnover among child welfare professionals. J Public Child Welfare. 2015;9(2):195\u2013216.","journal-title":"J Public Child Welfare"},{"issue":"1","key":"501_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00975140","volume":"3","author":"IL McCann","year":"1990","unstructured":"McCann IL, Pearlman LA. Vicarious traumatization: a framework for understanding the psychological effects of working with victims. J Traumatic Stress. 1990;3(1):131\u201349.","journal-title":"J Traumatic Stress"},{"key":"501_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1534765610395617","volume":"17","author":"BE Bride","year":"2011","unstructured":"Bride BE, Kintzle S. Secondary traumatic stress, job satisfaction, and occupational commitment in substance abuse counselors. Traumatology. 2011;17:22\u20138.","journal-title":"Traumatology"},{"key":"501_CR48","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s10461-020-02887-1","volume":"24","author":"KM Peavy","year":"2020","unstructured":"Peavy KM, Darnton J, Grekin P, Russo M, Banta Green CJ, Merrill JO, Fotinos C, Woolworth S, Soth S, Tsui JI. Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at high risk for HIV in an opioid treatment program. AIDS Behav. 2020;24:2469\u201372.","journal-title":"AIDS Behav"},{"key":"501_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0740-5472(99)00088-4","volume":"19","author":"DA Hein","year":"2000","unstructured":"Hein DA, Nunes E, Levin FR, Fraser D. Posttraumatic stress disorder and short-term outcome in early methadone treatment. J Sub Abuse Treat. 2000;19:31\u20137.","journal-title":"J Sub Abuse Treat"},{"issue":"6","key":"501_CR50","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1037\/tra0000312","volume":"10","author":"AH Ecker","year":"2018","unstructured":"Ecker AH, Hundt N. Posttraumatic stress disorder in opioid agonist therapy: a review. Psychol Trauma. 2018;10(6):636.","journal-title":"Psychol Trauma"},{"key":"501_CR51","unstructured":"Linde-Krieger LB, Meyerson BE, Huff AJ, Carter GA. An exploratory study of trauma, vicarious trauma, and lived substance use disorder among opioid treatment program staff: implications for staff functioning. (in review)"},{"issue":"2","key":"501_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.japh.2021.10.015","volume":"62","author":"JD Agley","year":"2022","unstructured":"Agley JD, Meyerson BE, Eldridge LA, Jun M, Vadiei N, Crosby RA, Bentele KG, Kennedy A, Anderson K. Exploration of pharmacist comfort with harm reduction behaviors: cross-sectional latent class analysis. J Am Pharm Assoc. 2022;62(2):432\u201340. https:\/\/doi.org\/10.1016\/j.japh.2021.10.015.","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"501_CR53","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.sapharm.2019.08.026","volume":"16","author":"BE Meyerson","year":"2020","unstructured":"Meyerson BE, Agley JD, Jayawardene W, Eldridge LA, Arora P, Smith C, Vadiei N, Kennedy A, Moehling T, PharmNet Research Team. Feasibility of a pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C\u2014Indiana 2019. Res Soc Admin Pharm. 2020;16(5):699\u2013709. https:\/\/doi.org\/10.1016\/j.sapharm.2019.08.026.","journal-title":"Res Soc Admin Pharm"},{"issue":"11","key":"501_CR54","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1111\/jan.14019","volume":"75","author":"W Jayawardene","year":"2019","unstructured":"Jayawardene W, Carter GA, Agley JD, Meyerson BE, Garcia J, Miller W. HIV pre-exposure prophylaxis uptake by advanced practice nurses: Interplay of agency, community and attitudinal factors. J Adv Nursing. 2019;75(11):2559\u201369. https:\/\/doi.org\/10.1111\/jan.14019.","journal-title":"J Adv Nursing"},{"key":"501_CR55","unstructured":"Brady B, Meyerson BE, Bentele KG. Flying blind: survey research among methadone and buprenorphine providers in Arizona. Survey methods: insights from the field 2023; https:\/\/surveyinsights.org\/?p=17985"},{"issue":"1","key":"501_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12310-015-9161-0","volume":"8","author":"CN Baker","year":"2016","unstructured":"Baker CN, Brown SM, Wilcox PD, Overstreet S, Arora P. Development and psychometric evaluation of the attitudes related to trauma-informed care (ARTIC) Scale. Sch Ment Heal. 2016;8(1):61\u201376.","journal-title":"Sch Ment Heal"},{"key":"501_CR57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jsat.2019.01.005","volume":"99","author":"LH Yang","year":"2019","unstructured":"Yang LH, Grivel MM, Anderson B, Bailey GL, Opler M, Wong LY, Stein MD. A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: evidence for construct validity. J Subst Abuse Treat. 2019;99:44\u201351. https:\/\/doi.org\/10.1016\/j.jsat.2019.01.005.","journal-title":"J Subst Abuse Treat"},{"key":"501_CR58","unstructured":"Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM. The life events checklist for DSM-5 (LEC-5). Instrument available from the National Center for PTSD at www.ptsd.va.gov. 2013."},{"issue":"4","key":"501_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0749-3797(98)00017-8","volume":"14","author":"VJ Felitti","year":"1998","unstructured":"Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) Study. Am J Prev Med. 1998;14(4):245\u201358. https:\/\/doi.org\/10.1016\/s0749-3797(98)00017-8.","journal-title":"Am J Prev Med"},{"issue":"6","key":"501_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jts.22059","volume":"28","author":"CA Blevins","year":"2015","unstructured":"Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489\u201398. https:\/\/doi.org\/10.1002\/jts.22059.","journal-title":"J Trauma Stress"},{"key":"501_CR61","doi-asserted-by":"crossref","unstructured":"Briere J. Psychometric review of the trauma symptom checklist-40, in B.H. Stamm (Ed). Measurement of stress, trauma, and adaptation. Lutherville, MD: Sidran Press, 1996. http:\/\/s1097954.instanturl.net\/trauma-symptom-checklist-40-tsi-40\/","DOI":"10.1037\/t06631-000"},{"issue":"4","key":"501_CR62","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/hsc.12554","volume":"26","author":"L Benuto","year":"2018","unstructured":"Benuto L, Singer J, Cummings C, Ahrendt A. The vicarious trauma scale: confirmatory factor analysis and psychometric properties with a sample of victim advocates. Health Soc Care Commun. 2018;26(4):564\u201371.","journal-title":"Health Soc Care Commun"},{"key":"501_CR63","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1186\/s12913-019-4803-9","volume":"19","author":"M Wilberforce","year":"2019","unstructured":"Wilberforce M, Sk\u00f6ldunger A, Edvardsson D. A Rasch analysis of the person-centered climate questionnaire\u2014staff version. BMC Health Serv Res. 2019;19:996. https:\/\/doi.org\/10.1186\/s12913-019-4803-9.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"501_CR64","doi-asserted-by":"publisher","first-page":"017250","DOI":"10.1136\/bmjopen-2017-017250","volume":"7","author":"L Cai","year":"2017","unstructured":"Cai L, Ahlstr\u00f6m G, Tang P, Ma K, Edvardsson D, Behm L, Fu H, Zhang J, Yang J. Psychometric evaluation of the Chinese version of the person-centred climate questionnaire\u2014staff version (PCQ-S). BMJ Open. 2017;7(8):017250.","journal-title":"BMJ Open"},{"issue":"1","key":"501_CR65","first-page":"81","volume":"61","author":"JY Yoon","year":"2015","unstructured":"Yoon JY, Roberts T, Grau B, Edvardsson D. Person-centered climate questionnaire-patient in English: a psychometric evaluation study in long-term care settings arch of. Gerontol Geriatrics. 2015;61(1):81\u20137.","journal-title":"Gerontol Geriatrics"},{"key":"501_CR66","unstructured":"National Harm Reduction Coalition. Foundational Principles Central to Harm Reduction. https:\/\/harmreduction.org\/about-us\/principles-of-harm-reduction\/ Accessed 23 April 2024."},{"issue":"2","key":"501_CR67","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/amp0000768","volume":"76","author":"EC Briggs","year":"2021","unstructured":"Briggs EC, Amaya-Jackson L, Putnam KT, Putnam FW. All adverse childhood experiences are not equal: the contribution of synergy to adverse childhood experience scores. Am Psychol. 2021;76(2):243.","journal-title":"Am Psychol"},{"key":"501_CR68","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/09687630802378864","volume":"17","author":"N Doukas","year":"2010","unstructured":"Doukas N, Cullen J. Recovered addicts working in the addiction field: pitfalls to substance abuse relapse. Drugs Educ Prev Policy. 2010;17:216\u201331.","journal-title":"Drugs Educ Prev Policy"},{"issue":"1","key":"501_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0740-5472(95)02019-5","volume":"13","author":"K Humphreys","year":"1996","unstructured":"Humphreys K, Noke J, Moos RH. Recovering substance abuse staff members\u2019 beliefs about addiction. J Sub Abuse Treat. 1996;13(1):75\u20138.","journal-title":"J Sub Abuse Treat"},{"issue":"4","key":"501_CR70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/10826089609045820","volume":"31","author":"JR Caplehorn","year":"1996","unstructured":"Caplehorn JR, Irwig L, Saunders JB. Attitudes and beliefs of staff working in methadone maintenance clinics. Subst Use Misuse. 1996;31(4):437\u201352. https:\/\/doi.org\/10.3109\/10826089609045820.","journal-title":"Subst Use Misuse"},{"key":"501_CR71","unstructured":"University of Michigan Behavioral Health Workforce Research Center. National analysis of peer support providers: Practice settings, requirements, roles and reimbursement. Ann Arbor, MI: UMSPH, 2019. [online]: https:\/\/www.behavioralhealthworkforce.org\/wp-content\/uploads\/2019\/10\/BHWRC-Peer-Workforce-Full-Report.pdf Accessed 25 May 2023."},{"issue":"1","key":"501_CR72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1108\/09696470310457469","volume":"10","author":"CL Wang","year":"2003","unstructured":"Wang CL, Ahmed PK. Organizational learning: a critical review. Learning Org. 2003;10(1):8\u201317.","journal-title":"Learning Org"},{"issue":"2","key":"501_CR73","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1037\/a0022284","volume":"25","author":"LJ Damschroder","year":"2011","unstructured":"Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psych of Addic Behav. 2011;25(2):194\u2013205.","journal-title":"Psych of Addic Behav"},{"key":"501_CR74","unstructured":"Zoom discussion about findings with OTP leadership of sample clinics. July 5, 2023."}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00501-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T01:02:38Z","timestamp":1733014958000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00501-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00501-6","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was provided by the University of Arizona Institutional Review Board (STUDY00002531). The participant consent process involved prospective participants voluntarily accessing the online landing page for the study, reviewing the study information and providing assent (online agreement) to proceed with the survey. If \u2018agree\u2019 was selected by the participant, they would be led to the anonymous survey instrument for completion. If \u2018disagree\u2019 was selected, they were led to a \u2018thank you for considering the study\u2019 message.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors provide publication consent for this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Meyerson, Linde-Krieger, Carter, Huff, Brady, Crosby, and De La Rosa have nothing to declare. Allison, Barakat, Ergurrola, Pava and Schaefer are employees of the opioid treatment program company from which the staff sample was drawn.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}